Calcium

    Written by:
    Daryl Nault, Gregory Lopez
    Fact-checked by:
    Giulia Guerrini, Conni Covington
    Last Updated: December 18, 2025

    Calcium is a macromineral that can be obtained through the diet, particularly in dairy products and, to a lesser extent, vegetables. It’s primarily used to support bone health, and there is some evidence that it supports cardiovascular health and women’s health.

    Safety InformationSafety Information
    New


    1.

    Sources and Structure

    1.1

    Sources

    Calcium is an essential mineral.

    1.2

    Biological Significance

    Calcium is most well known to serve as a major building block of bone in the human body, with there being anywhere from 1-2 kg of calcium in the human body that is 99% localized to bone tissue (skeleton and teeth).[6][7] The calcium tends to be stored in the form of hydroxyapatite crystals (Ca10(OH)2(PO4)6) formed by bone cells known as osteoblasts.[8]

    The remaining calcium is in a soluble form, found in the bloodstream and cells across the body, where it serves a vital role in aiding cellular signalling.[7][9]

    1.4

    Deficiency

    While the condition of bone deformation known as Rickets is commonly attributed to be due to a Vitamin D deficiency,[12] calcium also plays a pivotal role as the two are intricately linked when it comes to supporting the growth of bones (alongside other nutrients such as phosphorus and magnesium)[13] and instances of rickets in the presence of adequate Vitamin D have been reported.[14][15] While this condition affects children and youth exclusively, usually those under 18 months of age associated with lack of Vitamin D[13][16] and potentially in early adolescence with very low calcium intake,[17] adults don't experience any disease state specific to a lack of dietary calcium a lifetime of insufficient intake is one of the major risk factors in the promotion of osteoporosis.

    Both Vitamin D and calcium deficiency can lead to rickets, usually with Vitamin D presenting rickets within 1-2 years of age and calcium deficiency presenting rickets in childhood to early adolescence. Adults don't have a disease state specifically associated to calcium deficiency but it plays a major role in the onset of osteoporosis

    1.5

    Sufficiency and Excess

    The tolerable upper limit (TUL) of calcium is between 2,000-3,000 mg depending on age group, the higher TUL being for adolescents and pregnant or lactating women and the lower TUL of 2,000 mg for adults over the age of 50. Young adults and children have a TUL of 2,500 mg.[10][11]

    1.6

    Formulations and Variants

    Calcium phosphate (pentacalcium hydroxytriphosphate) is a form of calcium that is 2/3rds calcium by weight, and is an endogenous metabolite of calcium in the body (after forming with phosphorus in the intestines).[18]

    At 1,000mg (calcium equivalent) calcium phosphate supplementation is able to increase serum concentrations of calcium without affecting phosphorus levels in the postprandial state[19] although it has been noted to not influence fasting levels of calcium nor phosphorus over six weeks at 1,500mg.[20]

    image

    Calcium phosphate appears to be a viable form of calcium supplementation

    Coral calcium is a dietary supplement from coral (Coral calx or Praval bhasma) that is claimed to be better absorbed when compared to other forms of calcium supplementation, referencing a small study comparing a 525 mg dose of calcium as carbonate versus the same dose of calcium from coral from the Ryukyu islands (a 2:1 calcium:magnesium).[21] It's popularity as a supplement has at times been reported[22] to be associated with how the long lifespan of Okinawans are, in turn, associated with water intake that may have its mineral contents modified by the presence of high amounts of coral reef.[23]

    Coral is also known to possess hydroxyapatite,[24] a product of calcium in the human body that is very prominent in human bones and teeth. The relevance of orally ingested hydroxyapatite from coral calcium is currently unknown. Despite this, studies in rats do confirm that coral calcium is able to improve bone mineralization in models of bone loss.[25][26]

    Coral calcium is calcium derived from Coral calx. As it confers dietary calcium it appears to also work well as a bone health supplement (based on limited but coherent evidence). Whether it is better than traditional calcium supplements is unknown and there is no good evidence for any claim that cannot also be given for standard calcium supplements

    2.

    Molecular Targets

    2.1

    Calcium-Sensing Receptors (CaSRs)

    Calcium-sensing receptors (CaSRs) are receptors that respond to changes in calcium concentrations. Expressed in the kidneys, thyroid and the parathyroid which serve as a link between fluctuating calcium concentrations and manipulating the actions of parathyroid hormone and Vitamin D to help mitigate abnormal levels of calcium.[27] These receptors can be influenced by inflammation,[27] as both IL-6[28] and IL-1β[29] are known to increase the trancription rates and, ultimately, the amount of receptors.

    Calcium-sensing receptors are the receptors where changing levels of calcium in the body are 'detected', which then signal for other changes to initiate to help regulate calcium levels in the body

    3.

    Pharmacology

    3.1

    Absorption

    Calcium is absorbed by one of two ways in the intestines; a transporter-mediated process and a paracellular process.[30][31]

    The transporter-mediated process occurs primarily in the first two segments of the intestines, the duodenum and jejunum.[32][33] This is the stage of calcium absorption that has a rate-limit and can be regulated by both calcium levels in the body and Vitamin D[33] (although paracellular is still somewhat regulated[34]). It is an active transport system which starts with uptake through calcium channels (TRPV6 and TRPV5; previously known as CaT1 and CaT2 respectively) with TRPV6 being the variant favored in the intestines rather than the kidneys where TRPV5 dominates[35][36] while an L-type channel known as Cav1.3 also exists in the intestines that can also help transport calcium from the intestines.[37] The two receptors seem to have complementary roles with TRPV6 being more active in calcium reuptake during fasting and Cav1.3 being more active during feeding.[31][37]

    After initial uptake into the cell, calbindins (CBs) bind to calcium to carry it through the cell from the apical membrane to the basolateral membrane[31][38] and also help support the cell they are in by acting as buffering agents.[39] After the transfer, the calbindins pass calcium off to two proteins known as PMCA (mostly PMCA1b[40]) and NCX1; a pump and a Na+/Ca2+ exchanger respectively where the former is generally responsible for 80% of the calcium efflux.[41][42]

    Unlike the transport-mediated process, the paracellular (between cells) process occurs at all points in the intestines. It does occur in the ileum (segment of the large intestine that calcium transporters don't work in)[32] and also occurs throughout the entirety of the large intestine.[43] Generally speaking, this route of absorption is more relevant when chyme (digested food) travels through the intestines at a slower rate[44] and when the diet is sufficiently high in calcium.[30]

    Calcium absorption is affected by several factors. It varies based on environmental, age, and dietary considerations.[45][46][47] Postmenopausal women absorb calcium less than premenopausal women and thus require a higher dose of calcium than premenopausal women.[48][49] In healthy, premenopausal women, the proportion of dietary calcium absorbed varies from 17-58%, and is positively correlated with body mass index, dietary fat, serum vitamin D level, and parathyroid hormone concentrations. It is inversely correlated with total calcium intake, dietary fiber intake, alcohol consumption, physical activity, and symptoms of constipation.[50] Elderly women have a resistance to Vitamin D action that can contribute to their negative calcium balance, secondary hyperparathyroidism, and bone loss.[51] Additionally, weight loss is associated with elevated calcium requirement due to inadequate total calcium absorption. If this requirement is not met, it could activate the calcium-parathyroid hormone axis to absorb more calcium.[52]

    Calcium absorption increases from early to late pregnancy, decreases in early lactation, and then increases when weaning.[53][54][55][56][57]

    Calcium can be absorbed at any point in the intestines. Most absorption occurs quite soon after ingestion by active transports whereas there is a small concentration-dependent absorption that can occur for as long as chyme that contains calcium remains in the intestines. Absorption also differs according to age and environmental and dietary considerations.

    3.2

    Drug-Drug Interactions

    There have been many drug interactions reported among users of the various dosage forms of calcium. The type of interaction encountered will be different for every medication.

    Taking calcium with bisphosphonate drugs for osteoporosis or thyroid hormones like levothyroxine[58] can cause reduced drug absorption most likely due to forming insoluble complexes.[59].

    Calcium can also reduce the efficacy of some antivirals (e.g. amprenavir and zalcitabine), aspirin, several antibiotics (e.g. several fluoroquinolones, tetracycline, and several cephalosporins), and some antifungals (e.g. ketoconazole) can cause reduced drug efficacy.[59] Efficacy is also reduced for some drugs used for gastrointestinal issues (e.g. hyoscyamine, bisacodyl, and bismuth subcitrate), the antiplatlet drug ticlopidine, the calcium channel blocker verapamil, and the beta-blocker atenolol.[59] Efficacy of iron is also reduced by calcium.[59] Phosphate absorption is also reduced when calcium is taken concurrently.[59]

    Taking long-term lithium may cause hypercalcemia in 10%-60% of patients[60] and taking it concurrently can theoretically increase this risk. Serious interactions between calcium and the thiazide (such as hydrochlorothiazide) and thiazide-like (e.g. clopamide and chlorthalidone) can also occur. Taking these drugs together with calcium can cause milk-alkali syndrome, which is characterized by hypercalcemia, metabolic alkalosis, and renal failure.[59]

    Another serious interaction between calcium and digitoxin or digoxin can occur, leading to cardiotoxicity.[59]

    Calcium has many drug interactions, each of which can cause a different effect. While some interactions may be mild, calcium can cause more serious complications such as renal failure and reduced plasma concentration or efficacy of other drugs. Some of the more common drug interactions include aspirin, atenolol, bisacodyl, bismuth subcitrate, ciprofloxacin, doxycycline, tetracycline, and digoxin.

    4.

    Cardiovascular Health

    4.1

    Lipid Absorption

    Consumption of milk products with additional calcium (10-fold higher than normal) is able to increase fecal lipids by 139% and free fatty acids by 195%.[61]

    Calcium phosphate is known to be produced in the gut from calcium and phosphorus[18] where it appears able to precipitate intestinal substances such as bile acids or fatty acids.[62][63] Supplementation of 1,000mg calcium has been demonstrated to increase fecal bile acids while reducing fecal cholesterol concentrations.[63]

    4.2

    Platelets

    Dietary calcium intake has once been noted to be inversely related to clotting activity of platelets in farmers[64] and studies in research animals have noted dietary calcium to be associated with less platelet calcium responses[65] and handling[66] in hypertensive rats; thought to indicate a protective effect.

    While dietary calcium seems to have a facilitative role in platelets that reduces their overall aggregatory potential it is uncertain as to what effect high or low calcium intake in the diet or supplementation results in

    4.3

    Atherosclerosis

    Fatty acid binding protein (FABP), specifically FABP4, is both a cytosolic and plasma protein involved in trafficking fatty acids. It appears to have an additive effect on lipids and atherosclerotic buildup due to knockout mice being resistant to these states[67][68] and its release from adipocytes (and macrophages) is known to be partially dependent on calciums action as assessed by 0.5-3µM ionomycin.[69] Increases in FABP4 levels have been detected in vitro with other agonists that stimulate calcium release such as capsaicin.[70] There are currently no human studies assessing dietary calcium supplementation and it's relation to serum FAB4.

    Calcium is involved in the release of FABP4 but an interaction with this protein and supplementation of calcium itself is not yet known

    The presence of calcium in arteries (Coronary artery calcium; CAC) is known to be predictive of cardiovascular disease and coronary heart disease even in adults without cardiovascular diseases.[71][72] This is thought to be related to arterial stiffness related to calcium, related to both Vitamin D intake[73] and proteins influenced by Vitamin K intake.[74]

    5.

    Fat Mass and Obesity

    5.1

    Mechanisms

    Calcium's role in the adipocyte is that of an intracellular messenger, being released in response to various agonists such as capsaicin.[70]

    6.

    Skeletal and Bone Mass

    6.1

    Osteoporosis

    Osteoporosis, a weakening of skeletal bones due to loss of bone mass, is a relatively common bone ailment in the first world with one study noting an estimated 10.3% prevalence of osteoporosis in those above the age of 50 in the USA (2010) and a further 43.9% prevalence of low bone mass without osteoporosis.[75] Calcium is investigated in its role in osteoporosis due both to its pivotal role in being a large constituent of bone mass but also due to generally low intake of calcium in populations which suffer from osteoporosis and reduced bone mass.[76][77]

    6.2

    Fractures

    Fractured bones are known to be a large risk during advancing age due to a combination of reduced bone integrity and diminishing muscular strength,[78] largely tied in to osteoporotic pathology.[79] Beyond other preventative measures such as resistance training which is effectively preventative[80] calcium supplementation is also investigated due to aiding in bone integrity during osteoporosis.

    A review[81] found only two interventions using 800mg calcium (one with Vitamin D using milk[82] and the other supplementation[83]) and 50 publications assessing correlations between calcium intake and fracture rates predominately in the elderly; the authors found that, overall, there was no significant and consistent relationship between fracture rates and dietary calcium, milk intake, or intake of dairy overall.[81] Despite this, meta-analyses assessing the usage of calcium in conjunction with Vitamin D do support the preventative benefits of supplementing both to assist in reducing the risk of fractures showing a 15% reduction of total fractures (Summary relative risk estimate (SRRE) of 0.85; 95% CI 0.73-0.98) with a 30% reduction in hip fractures specifically (SRRE 0.70; 95% CI 0.56-0.87).[84]

    While supplementing calcium alone does not appear to be sufficient enough to prevent the risk of fractures in the elderly, combining calcium and Vitamin D supplementation does appear to be effective

    7.

    Interactions with Hormones

    7.1

    Testosterone

    Four week supplementation of calcium in active and sedentary males (35mg/kg calcium as gluconate) failed to increase testosterone in sedentary men relative to their own baseline, and while an increase in testosterone was seen in the active group supplemented with calcium it was not significantly different than the active group given no supplement.[85]

    No significant influence on testosterone concentrations

    8.

    Interactions with Cancer Metabolism

    8.1

    Colon Cancer

    Soluble bile acids (rather than total fecal bile acids) contributes to colonic epithelium toxicity[86][87] and are thought to underlie colonic DNA damage and genotoxicity;[88][89] due to the ability of calcium to precipitate these bile acids[61][90][91] secondary to forming amorphous calcium phosphate[92] it is thought to be protective against colon cancer.

    Supplementation of 1,000mg calcium for four weeks in otherwise healthy adults has failed to alter the genotoxicity of fecal water, which may be due to barely affecting bile acids in fecal water (despite significantly reducing insoluble bile acids).[63]

    9.

    Pregnancy and Lactation

    9.1

    Hypertension

    Hypertension has been estimated to complicate 5% of worldwide pregnencies and 11% of first time pregnancies;[93] due to this being associated with morbidity safe interventions to prevent hypertension and a related condition, pre-eclampsia, are sought after. Calcium is investigated as an inverse relationship between calcium intake and blood pressure during pregnancy is known[94] which extends to pre-eclampsia.[95] Low blood calcium also appears to be a useful predictor of both hypertension[96] and pre-eclampsia[97] during pregnancy.

    A Cochrane review on the topic of calcium supplementation during pregnancy has found that, in 13 studies that assess high dose calcium supplementation (1,000mg or greater) the average risk of high blood pressure appeared to be reduced (RR 0.65; 95% CI of 0.53-0.81) alongside a significant reduction in the risk of developing pre-eclampsia (RR 0.45; 95% CI of 0.31-0.65);[98] the effect was most significant in women who were at greater risk of pre-eclampsia as assessed by other factors and women who had low dietary calcium intake.[98]

    It appears that supplementation of 1,000mg calcium during pregnancy is able to reduce the risk of developing high blood pressure and pre-clampsia with particular potency in people who have a low dietary calcium intake. Increasing calcium intake from food products is also able to confer this protective effect.

    It is known that the risk of pre-eclampsia is increased with high BMI during pregnancy (greater than 35) and with high blood pressure before pregnancy,[99] calcium supplementation of 2g a day for the second half of pregnancy appears to be unable of normalizing this risk.[100]

    While calcium reduces the risk of pre-eclampsia related to low dietary calcium intake, it does not appear to significantly the risk of pre-eclampsia caused by other factors such as excessive body weight

    Based on observational studies suggesting that increased maternal calcium intake is associated with reduced blood pressure in the child[101][102] the topic has been reviewed[103] assessing four trials using calcium supplementation[104][105][106][107] which found that, when assessing the mother's intake of calcium during pregnancy, that the child's blood pressure in youth appeared to be inversely associated with the mother's calcium intake.

    This effect may only persist in women who were hypertensive during pregnancy[106] as one of these trials in women with low dietary calcium intake (West Africa) given 1,500 mg calcium during the second half of pregnancy failed to find an effect of supplementation when the mothers had normal blood pressure.[107]

    Supplemental calcium during pregnancy may have a beneficial effect on the blood pressure of the offspring during youth, potentially related to alleviating the high blood pressure of the mother

    9.2

    Delivery

    In studies assessing the delivery of the child, it was found that supplementation of calcium (1.8g) throughout the second half of pregnancy was associated with less usage of antenatal corticosteroids[108] and less complications with preterm birth (rupture of membranes and admittance for threatened preterm labour).[108]

    9.3

    Bone Mineral Density

    In women who just gave birth (5 days postpartum) given calcium either through dairy products (932mg calcium) or via supplementation (1000mg) for six months, both groups were associated with increased bone mineral density and bone mineral content and were not significantly different.[109]

    10.

    Interactions with Organ Systems

    10.1

    Intestines

    Past research has suggested that soluble fatty acids and secondary bile acids, which act as surfactants in the intestines, may have a role in the promotion of cancer due to stimulating colonic crypt cells[110] which may be indicative of increased risk of colon cancer.[111] Calcium has been investigated in regards to colon cancer as it has a negative correlation with the prevalence of this form of cancer[112] and has shown a suppressive effect when tested in mice subject to a combination of fatty acids and intestinal inflammation.[110] It is thought that excess calcium administration can combine with these soluble lipids and form inert calcium soaps for elimination[110] which has been noted in humans given milk with an increased calcium content (10-fold more than normal) which successfully increased elimination of fatty and bile acids in the feces.[61]

    Studies in humans using supplemental calcium in various instances of intestinal inflammation have found a reduction in intestinal hyperproliferation following intestinal bypass (2,400 or 3,600mg calcium carbonate for twelve weeks)[113] and in subjects with a familial history of colon cancer given 700mg calcium carbonate supplementation (1.3-1.5g calcium daily in conjunction with diet).[114] In both cases the level of crypt cell proliferation has reduced.

    It is thought that soluble fatty acids in the intestines may damage intestinal tissue which subsequently play a role in promoting colon cancer. Calcium supplementation, or higher than normal calcium intake, seems to protect against this effect

    11.

    Nutrient-Nutrient Interactions

    11.1

    Vitamin D

    In Japanese men who were subject to dietary analysis, low dietary calcium appeared to be associated with increased arterial stiffness (assessed by ba-PWV); while vitamin D itself has no relation it appeared that there was even less arterial stiffness in those who consumed high levels of calcium and vitamin D.[73]

    11.2

    Absorption Modifiers

    In vitro, sugar alcohols appear to enhance the absorption of calcium in the small intestine (ileum and jejunum) as well as in the large intestine.[115] Tested sugar alcohols (Erythriol, xylitol, maltitol, lactitol, sorbitol, and palatinit) all appear to enhance absorption of calcium overall with some differences in where they affect absorption.[115]

    This effect has also been noted with oligosaccharides[116][117][118] and is thought to be related to changes in the solubility of calcium;[119][120] fermentation of these molecules and production of SCFAs can alter the acidity of the lumen which is known to increase passive (paracellular) calcium absorption.[121]

    Absorption of calcium appears to be increased by fermentable and partially fermentable carbohydrates, possibly related to the reduced colonic pH increasing the solubility of calcium

    12.

    Safety and Toxicology

    12.1

    General

    The maximum dose of elemental calcium that should be taken at a time is 500 mg to prevent unwanted effects on absorption of calcium and parathyroid hormone.More specifically, absorption of calcium decreases two-fold when calcium is overused, which may lead to bone resorption and increase in parathyroid hormone levels. [122] In other words, calcium supplements might interfere with how well our bones absorb calcium. [123] Natural calcium products have also been reported to contain measurable lead content. [124] While minimum calcium intake varies by age group and pregnancy, maximum calcium intake is consistently 2500 mg per day for everyone. Calcium intake that exceeds the recommended maximum daily dose can result in adverse effects and can interfere with absorption of other minerals, such as zinc, phosphorus, and magnesium.[122]

    12.2

    Human Toxicity

    In a small observational study, elderly women taking calcium supplementation for five or more years had increased odds of developing dementia (OR 2.10), including vascular and mixed-dementia, but not Alzheimer’s dementia. However, the dose is not mentioned in this study.[125]

    When taking large amounts of calcium carbonate (>20 g/day) for a prolonged period of time, there may be a risk of hypercalcemia, milk-alkali syndrome, nephrocalcinosus, and renal insufficiency.[126]

    Fatal prostate cancer has also been associated with calcium intakes from food or supplementation in amounts 1500 mg per day.[122] Other studies suggest consuming 2000 mg/day might increase risk for prostate cancer.[127][128] However, there is contradictory research that indicates no association between calcium intake and overall prostate cancer risk..[129][130] One of these studies found an increased risk of advanced or fatal prostate cancer, however, while overall risk of prostate cancer was unaffected.[129]

    In one meta-analysis, the authors claimed a possible increased risk of cardiovascular disease with calcium use, although the results of the analysis were not statistically significant.[131] In a different meta-analysis, calcium supplementation of 500 mg or greater per day without coadministered vitamin D was linked with an increased risk of myocardial infarction.[132] Furthermore, a re-analysis of one study, where postmenopausal women were taking 1 g of calcium and 400 IU of vitamin D daily, found that there was interaction between personal calcium use or allocated calcium and vitamin D use and cardiovascular events. Two meta-analyses of 11 placebo controlled trials found that calcium or calcium with vitamin D modestly increased the risk of cardiovascular events, specifically myocardial infarction and stroke.

    Meta-analyses of calcium supplementation suggest that it may be linked to increased risk of cardiovascular disease. Possible links with dementia and prostate cancer exist, but more research is needed to confirm this correlation.

    12.3

    Side Effects with Safe Usage

    Calcium supplementation has been reported to cause belching, flatulence, nausea, gastrointestinal discomfort, constipation, excessive abdominal cramping, bloating, severe diarrhea, and abdominal pain.[126][134]

    12.4

    Withdrawal

    There is evidence that support that the benefits from calcium supplementation disappear after consistent use is withdrawn.[135][136]

    12.5

    Case Studies

    A handful of case reports have shown that adults who take calcium supplementation can potentially experience side effects; one person acquired acute pancreatitis after taking 1800 mg calcium carbonate daily due to having their thyroid removed,[137] another developed kidney stones due to 3000-5000 mg of calcium phosphate for osteoporosis prevention, [138] and a final report of 3 patients developed hypercalcemia taking various doses of calcium carbonate for osteoporosis and heart burn.[139]

    One case study found an elderly woman who used calcium carbonate 500 my two-three times daily for osteoporosis suffered from red, hot, swollen joints that was found to be connected to her calcium intake leading the author to conclude “some people are peculiarly sensitive to oral calcium supplementation”.[140] An additional case report found that a lactating woman who used calcium carbonate in moderate doses suffered from hypercalcemia.[141] Lastly a case report on 3 premature infants who were given 195.3 mg of calcium lactate and 290.7 mg calcium glycerophosphate, developed blockage of a part of their intestines.[142]

    There have been reports of severe hypercalcemia in Williams-Beuren syndrome patients. This is caused by a deleted gene, which is responsible for regulating the intestinal absorption of calcium.[143] Calcium supplementation may be cautioned in people who suffer from this condition.

    Additionally, in patients with renal impairment, doses as low of 4g/day of calcium may cause hypercalcemia and milk-alkali syndrome[144]

    There has also been evidence that calcium supplementation is linked with the severity of pseudoxanthoma elasticum (PXE) lesions in people affected by this condition.[145]

    References

    1. ^Plantz MA, Bittar KDietary Calcium and Supplementation.StatPearls.(2025 Jan)
    2. ^Yu E, Sharma SPhysiology, Calcium.StatPearls.(2025 Jan)
    3. ^Ishitani K, Itakura E, Goto S, Esashi TCalcium absorption from the ingestion of coral-derived calcium by humans.J Nutr Sci Vitaminol (Tokyo).(1999 Oct)
    4. ^Kim SK, Ravichandran YD, Kong CSApplications of calcium and its supplement derived from marine organisms.Crit Rev Food Sci Nutr.(2012)
    5. ^Fritz K, Taylor K, Parmar MCalcium Carbonate.StatPearls.(2025 Jan)
    6. ^Booth A, Camacho PA Closer look at calcium absorption and the benefits and risks of dietary versus supplemental calciumPostgrad Med.(2013)
    7. ^Lanham-New SAImportance of calcium, vitamin D and vitamin K for osteoporosis prevention and treatmentProc Nutr Soc.(2008)
    8. ^Prakasam M et al.Fabrication, Properties and Applications of Dense Hydroxyapatite: A ReviewJ Funct Biomater.(2015)
    9. ^Jacobson J, Duchen MRInterplay between mitochondria and cellular calcium signallingMol Cell Biochem.(2004)
    10. ^Dietary Reference Intakes for Calcium and Vitamin D(2010)
    11. ^Ross AC et al.The 2011 Dietary Reference Intakes for Calcium and Vitamin D: what dietetics practitioners need to knowJ Am Diet Assoc.(2011)
    12. ^Rajakumar KVitamin D, cod-liver oil, sunlight, and rickets: a historical perspectivePediatrics.(2003)
    13. ^Pettifor JMNutritional rickets: deficiency of vitamin D, calcium, or both?Am J Clin Nutr.(2004)
    14. ^Kooh SW et al.Rickets due to calcium deficiencyN Engl J Med.(1977)
    15. ^Legius E et al.Rickets due to dietary calcium deficiencyEur J Pediatr.(1989)
    16. ^Majid Molla A et al.Risk factors for nutritional rickets among children in KuwaitPediatr Int.(2000)
    17. ^Pettifor JM et al.Rickets in children of rural origin in South Africa: is low dietary calcium a factor?J Pediatr.(1978)
    18. ^Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids
    19. ^Trautvetter U, Kiehntopf M, Jahreis GPostprandial effects of calcium phosphate supplementation on plasma concentration-double-blind, placebo-controlled cross-over human studyNutr J.(2013 Mar 8)
    20. ^Grimm M, Müller A, Hein G, Fünfstück R, Jahreis GHigh phosphorus intake only slightly affects serum minerals, urinary pyridinium crosslinks and renal function in young womenEur J Clin Nutr.(2001 Mar)
    21. ^Ishitani K et al.Calcium absorption from the ingestion of coral-derived calcium by humansJ Nutr Sci Vitaminol (Tokyo).(1999)
    22. ^Kim SK, Ravichandran YD, Kong CSApplications of calcium and its supplement derived from marine organismCrit Rev Food Sci Nutr.(2012)
    23. ^Ramos AA, Inoue Y, Ohde SMetal contents in Porites corals: Anthropogenic input of river run-off into a coral reef from an urbanized area, OkinawaMar Pollut Bull.(2004)
    24. ^J. Hu et al.Production and analysis of hydroxyapatite from Australian corals via hydrothermal processJournal of Materials Science Letters.(2001)
    25. ^Reddy PN, Lakshmana M, Udupa UVEffect of Praval bhasma (Coral calx), a natural source of rich calcium on bone mineralization in ratsPharmacol Res.(2003)
    26. ^Banu J et al.Dietary coral calcium and zeolite protects bone in a mouse model for postmenopausal bone lossNutr Res.(2012)
    27. ^Hendy GN, Canaff LCalcium-sensing receptor, proinflammatory cytokines and calcium homeostasisSemin Cell Dev Biol.(2016)
    28. ^Canaff L, Zhou X, Hendy GNThe proinflammatory cytokine, interleukin-6, up-regulates calcium-sensing receptor gene transcription via Stat1/3 and Sp1/3J Biol Chem.(2008)
    29. ^Canaff L, Hendy GNCalcium-sensing receptor gene transcription is up-regulated by the proinflammatory cytokine, interleukin-1beta. Role of the NF-kappaB PATHWAY and kappaB elementsJ Biol Chem.(2005)
    30. ^Bronner FMechanisms of intestinal calcium absorptionJ Cell Biochem.(2003)
    31. ^Diaz de Barboza G, Guizzardi S, Tolosa de Talamoni NMolecular aspects of intestinal calcium absorptionWorld J Gastroenterol.(2015)
    32. ^Bronner F, Pansu D, Stein WDAn analysis of intestinal calcium transport across the rat intestineAm J Physiol.(1986)
    33. ^Bronner F, Buckley MCalcium-binding protein biosynthesis in the rat: Regulation by calcium and 1,25-dihydroxyvitamin D3Arch Biochem and Biophys.(1980)
    34. ^Alexander RT, Rievaj J, Dimke HParacellular calcium transport across renal and intestinal epitheliaBiochem Cell Biol.(2014)
    35. ^Peng JB et alMolecular cloning and characterization of a channel-like transporter mediating intestinal calcium absorptionJ Biol Chem.(1999)
    36. ^Nijenhuis T et al.Localization and regulation of the epithelial Ca2+ channel TRPV6 in the kidneyJ Am Soc Nephrol.(2003)
    37. ^Kellett GLAlternative perspective on intestinal calcium absorption: proposed complementary actions of Ca(v)1.3 and TRPV6Nutr Rev.(2011)
    38. ^Nägerl UV et al.Binding kinetics of calbindin-D(28k) determined by flash photolysis of caged Ca(2+)Biophys J.(2000)
    39. ^Schwaller BCytosolic Ca2+ buffersCold Spring Harb Perspect Biol.(2010)
    40. ^Centeno VA et al.Dietary calcium deficiency increases Ca2+ uptake and Ca2+ extrusion mechanisms in chick enterocytesComp Biochem Physiol A Mol Integr Physiol.(2004)
    41. ^Ghijsen WE, De Jong MD, Van Os CHKinetic properties of Na+/Ca2+ exchange in basolateral plasma membranes of rat small intestineBiochim Biophys Acta.(1983)
    42. ^Freeman TC et al.Cellular and regional expression of transcripts of the plasma membrane calcium pump PMCA1 in rabbit intestineAm J Physiol.(1995)
    43. ^Favus MJFactors that influence absorption and secretion of calcium in the small intestine and colonAm J Physiol.(1985)
    44. ^Pansu D et alSolubility and intestinal transit time limit calcium absorption in ratsJ Nutr.(1993)
    45. ^Celotti F, Bignamini ADietary calcium and mineral/vitamin supplementation: a controversial problemJ Int Med Res.(1999 Jan-Feb)
    46. ^Miller GD, Jarvis JK, McBean LDThe importance of meeting calcium needs with foodsJ Am Coll Nutr.(2001 Apr)
    47. ^Wigertz K, Palacios C, Jackman LA, Martin BR, McCabe LD, McCabe GP, Peacock M, Pratt JH, Weaver CMRacial differences in calcium retention in response to dietary salt in adolescent girlsAm J Clin Nutr.(2005 Apr)
    48. ^Heaney RP, Recker RR, Saville PDMenopausal changes in calcium balance performanceJ Lab Clin Med.(1978 Dec)
    49. ^Heaney RP, Recker RR, Stegman MR, Moy AJCalcium absorption in women: relationships to calcium intake, estrogen status, and ageJ Bone Miner Res.(1989 Aug)
    50. ^Wolf RL, Cauley JA, Baker CE, Ferrell RE, Charron M, Caggiula AW, Salamone LM, Heaney RP, Kuller LHFactors associated with calcium absorption efficiency in pre- and perimenopausal womenAm J Clin Nutr.(2000 Aug)
    51. ^Pattanaungkul S, Riggs BL, Yergey AL, Vieira NE, O'Fallon WM, Khosla SRelationship of intestinal calcium absorption to 1,25-dihydroxyvitamin D 1,25(OH)2D levels in young versus elderly women: evidence for age-related intestinal resistance to 1,25(OH)2D actionJ Clin Endocrinol Metab.(2000 Nov)
    52. ^Cifuentes M, Riedt CS, Brolin RE, Field MP, Sherrell RM, Shapses SAWeight loss and calcium intake influence calcium absorption in overweight postmenopausal womenAm J Clin Nutr.(2004 Jul)
    53. ^O'Brien KO, Nathanson MS, Mancini J, Witter FRCalcium absorption is significantly higher in adolescents during pregnancy than in the early postpartum periodAm J Clin Nutr.(2003 Dec)
    54. ^Vargas Zapata CL, Donangelo CM, Woodhouse LR, Abrams SA, Spencer EM, King JCCalcium homeostasis during pregnancy and lactation in Brazilian women with low calcium intakes: a longitudinal studyAm J Clin Nutr.(2004 Aug)
    55. ^Cross NA, Hillman LS, Allen SH, Krause GF, Vieira NECalcium homeostasis and bone metabolism during pregnancy, lactation, and postweaning: a longitudinal studyAm J Clin Nutr.(1995 Mar)
    56. ^Kalkwarf HJ, Specker BL, Heubi JE, Vieira NE, Yergey ALIntestinal calcium absorption of women during lactation and after weaningAm J Clin Nutr.(1996 Apr)
    57. ^Ritchie LD, Fung EB, Halloran BP, Turnlund JR, Van Loan MD, Cann CE, King JCA longitudinal study of calcium homeostasis during human pregnancy and lactation and after resumption of mensesAm J Clin Nutr.(1998 Apr)
    58. ^Schneyer CRCalcium carbonate and reduction of levothyroxine efficacyJAMA.(1998 Mar 11)
    59. ^Yetley EAMultivitamin and multimineral dietary supplements: definitions, characterization, bioavailability, and drug interactionsAm J Clin Nutr.(2007 Jan)
    60. ^Jones BJ, Twomey PJRequesting patterns for serum calcium concentration in patients on long-term lithium therapyInt J Clin Pract.(2009 Jan)
    61. ^Govers MJ, Termont DS, Lapré JA, Kleibeuker JH, Vonk RJ, Van der Meer RCalcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humansCancer Res.(1996 Jul 15)
    62. ^Van der Meer R, Lapré JA, Govers MJ, Kleibeuker JHMechanisms of the intestinal effects of dietary fats and milk products on colon carcinogenesisCancer Lett.(1997 Mar 19)
    63. ^Ditscheid B, Keller S, Jahreis GFaecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differencesEur J Nutr.(2009 Feb)
    64. ^Renaud S, Morazain R, Godsey F, Dumont E, Thevenon C, Martin JL, Mendy FNutrients, platelet function and composition in nine groups of French and British farmersAtherosclerosis.(1986 Apr)
    65. ^Rao RM, Yan Y, Wu YDietary calcium reduces blood pressure, parathyroid hormone, and platelet cytosolic calcium responses in spontaneously hypertensive ratsAm J Hypertens.(1944 Dec)
    66. ^Oshima T, Young EW, Hermsmeyer K, McCarron DAModification of platelet and lymphocyte calcium handling and blood pressure by dietary sodium and calcium in genetically hypertensive ratsJ Lab Clin Med.(1992 Feb)
    67. ^Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GSImproved glucose and lipid metabolism in genetically obese mice lacking aP2Endocrinology.(2000 Sep)
    68. ^Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, Parker RA, Suttles J, Fazio S, Hotamisligil GS, Linton MF.Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosisNat Med.(2001 Jun)
    69. ^Schlottmann I, Ehrhart-Bornstein M, Wabitsch M, Bornstein SR, Lamounier-Zepter VCalcium-dependent release of adipocyte fatty acid binding protein from human adipocytesInt J Obes (Lond).(2014 Sept)
    70. ^Kida R, Yoshida H, Murakami M, Shirai M, Hashimoto O, Kawada T, Matsui T, Funaba MDirect action of capsaicin in brown adipogenesis and activation of brown adipocytesCell Biochem Funct.(20016 Jan)
    71. ^Gepner AD, Young R, Delaney JA, Tattersal MC, Blaha MJ, Post WS, Gottesman RF, Kronmal R, Budoff MJ, Burke GL, Folsom AR, Liu K, Kaufman J, Stein JHComparison of coronary artery calcium presence, carotid plaque presence, and carotid intima-media thickness for cardiovascular disease prediction in the Multi-Ethnic Study of AtherosclerosisCirc Cardiovasc Imaging.(2015 Jan)
    72. ^Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, Budoff MJ, Liu K, Shea S, Szklo M, Tracy RP, Watson KE, Burke GLCoronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA)Arch Intern Med.(2008 Jun)
    73. ^Uemura H, Katsuura-Kamano S, Yamaguchi M, Nakamoto M, Hiyoshi M, Arisawa KAssociation between dietary calcium intake and arterial stiffness according to dietary vitamin D intake in menBr J Nutr.(2014 Oct)
    74. ^Pivin E, Ponte B, Pruijm M, Ackermann D, Guessous I, Ehret G, Liu YP, Drummen NE, Knapen MH, Pechere-Bertschi A, Paccaud F, Mohaupt M, Vermeer C, Staessen JA, Vogt B, Martin PY, Burnier M, Bochud MInactive Matrix Gla-Protein Is Associated With Arterial Stiffness in an Adult Population-Based StudyHypertension.(2015 Jul)
    75. ^Wright NC et al.The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spineJ Bone Miner Res.(2014)
    76. ^Bailey RL et al.Estimation of total usual calcium and vitamin D intakes in the United StatesJ Nutr.(2010)
    77. ^Wallace TC et al.Calcium and vitamin D disparities are related to gender, age, race, household income level, and weight classification but not vegetarian status in the United States: Analysis of the NHANES 2001-2008 data setJ Am Coll Nutr.(2013)
    78. ^Ensrud KEEpidemiology of fracture risk with advancing ageJ Gerontol A Biol Sci Med Sci.(2013)
    79. ^Cummings SR, Melton LJEpidemiology and outcomes of osteoporotic fracturesLancet.(2002)
    80. ^Karinkanta S et al.Combined resistance and balance-jumping exercise reduces older women's injurious falls and fractures: 5-year follow-up studyAge Ageing.(2015)
    81. ^Bolland MJ et alCalcium intake and risk of fracture: systematic reviewBMJ.(2015)
    82. ^Lau EM, Woo J, Lam V, Hong AMilk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone lossJ Bone Miner Res.(2001)
    83. ^Chevalley T et al.Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patientsOsteoporos Int.(1994)
    84. ^Weaver CM et al.Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis FoundationOsteoporos Int.(2016)
    85. ^Cinar V, Baltaci AK, Mogulkoc R, Kilic MTestosterone levels in athletes at rest and exhaustion: effects of calcium supplementationBiol Trace Elem Res.(2009 Summer)
    86. ^Nagengast FM, Grubben MJ, van Munster IPRole of bile acids in colorectal carcinogenesisEur J Cancer.(1995 Jul-Aug)
    87. ^Roberton AMRoles of endogenous substances and bacteria in colorectal cancerMutat Res.(1993 Nov)
    88. ^Glinghammar B, Inoue H, Rafter JJDeoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-kB and AP-1Carcinogenesis.(2002 May)
    89. ^Powolny A, Xu J, Loo GDeoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53Int J Biochem Cell Biol.(2001 Feb)
    90. ^Differential binding of glycine- and taurine-conjugated bile acids to insoluble calcium phosphate
    91. ^Govers MJ, Termont DS, Van Aken GA, Van der Meer RCharacterization of the adsorption of conjugated and unconjugated bile acids to insoluble, amorphous calcium phosphateJ Lipid Res.(1994 May)
    92. ^Termine JD, Posner ASCalcium phosphate formation in vitro. I. Factors affecting initial phase separationArch Biochem Biophys.(1970 Oct)
    93. ^Villar J, Abalos E, Nardin JM, Merialdi M, Carroli GStrategies to prevent and treat preeclampsia: evidence from randomized controlled trialsSemin Nephrol.(2004 Nov)
    94. ^Belizán JM, Villar J, Repke JThe relationship between calcium intake and pregnancy-induced hypertension: up-to-date evidenceAm J Obstet Gynecol.(1988 Apr)
    95. ^Segovia BL, Vega IT, Villarreal EC, Licona NAHypocalciuria during pregnancy as a risk factor of preeclampsiaGinecol Obstet Mex.(2004 Nov)
    96. ^Kumru S, Aydin S, Simsek M, Sahin K, Yaman M, Ay GComparison of serum copper, zinc, calcium, and magnesium levels in preeclamptic and healthy pregnant womenBiol Trace Elem Res.(2003 Aug)
    97. ^Isezuo SA, Ekele BAEclampsia and abnormal QTcWest Afr J Med.(2004 Spring)
    98. ^Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MRCalcium supplementation during pregnancy for preventing hypertensive disorders and related problemsCochrane Database Syst Rev.(2014 Jun)
    99. ^Duckitt K, Harrington DRisk factors for pre-eclampsia at antenatal booking: systematic review of controlled studiesBMJ.(2005 Mar)
    100. ^Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, Goldenberg RL, Joffe GRisk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study GroupAm J Obstet Gynecol.(1997 Nov)
    101. ^Gillman MW et al.Maternal calcium intake and offspring blood pressureCirculation.(2004)
    102. ^McGarvey ST et al.Maternal prenatal dietary potassium, calcium, magnesium, and infant blood pressureHypertension.(1991)
    103. ^Jamshidi F, Kelishadi RA systematic review on the effects of maternal calcium supplementation on offspring's blood pressureJ Res Med Sci.(2015)
    104. ^Hatton DC, Harrison-Hohner J, Coste S, Reller M, McCarron DGestational calcium supplementation and blood pressure in the offspringAm J Hypertens.(2003)
    105. ^Belizán JM et al.Long-term effect of calcium supplementation during pregnancy on the blood pressure of offspring: follow up of a randomised controlled trialBMJ.(1997)
    106. ^Hiller JE et al.Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trialAust N Z J Obstet Gynaecol.(2007)
    107. ^Hawkesworth S et al.Effect of maternal calcium supplementation on offspring blood pressure in 5- to 10-y-old rural Gambian childrenAm J Clin Nutr.(2010)
    108. ^Crowther CA, Hiller JE, Pridmore B, Bryce R, Duggan P, Hague WM, Robinson JSCalcium supplementation in nulliparous women for the prevention of pregnancy-induced hypertension, preeclampsia and preterm birth: an Australian randomized trial. FRACOG and the ACT Study GroupAust N Z J Obstet Gynaecol.(1999 Feb)
    109. ^Malpeli A, Apezteguia M, Mansur JL, Armanini A, Macías Couret M, Villalobos R, Kuzminczuk M, Gonzalez HFCalcium supplementation, bone mineral density and bone mineral content. Predictors of bone mass changes in adolescent mothers during the 6-month postpartum periodArch Latinoam Nutr.(2012 Mar)
    110. ^Wargovich MJ, Eng VW, Newmark HLCalcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epitheliumCancer Lett.(1984 Jul)
    111. ^Lipkin MBiomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjectsCancer Res.(1988 Jan)
    112. ^Sorenson AW, Slattery ML, Ford MHCalcium and colon cancer: a reviewNutr Cancer.(1988)
    113. ^Steinbach G, Lupton J, Reddy BS, Kral JG, Holt PREffect of calcium supplementation on rectal epithelial hyperproliferation in intestinal bypass subjectsGastroenterology.(1994 May)
    114. ^Lipkin M, Friedman E, Winawer SJ, Newmark HColonic epithelial cell proliferation in responders and nonresponders to supplemental dietary calciumCancer Res.(1989 Jan 1)
    115. ^Mineo H, Hara H, Tomita FSugar alcohols enhance calcium transport from rat small and large intestine epithelium in vitroDig Dis Sci.(2002)
    116. ^Mineo H et al.Two-week feeding of difructose anhydride III enhances calcium absorptive activity with epithelial cell proliferation in isolated rat cecal mucosaNutrition.(2006)
    117. ^Saito K et al.Effects of DFA IV in rats: calcium absorption and metabolism of DFA IV by intestinal microorganismsBiosci Biotechnol Biochem.(1999)
    118. ^Hara H, Suzuki T, Aoyama YIngestion of the soluble dietary fibre, polydextrose, increases calcium absorption and bone mineralization in normal and total-gastrectomized ratsBr J Nutr.(2000)
    119. ^Levrat MA, Rémésy C, Demigné CHigh propionic acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulinJ Nutr.(1991)
    120. ^Younes H, Demigné C, Rémésy CAcidic fermentation in the caecum increases absorption of calcium and magnesium in the large intestine of the ratBr J Nutr.(1996)
    121. ^Duflos C, Bellaton C, Pansu D, Bronner FCalcium solubility, intestinal sojourn time and paracellular permeability codetermine passive calcium absorption in ratsJ Nutr.(1995)
    122. ^Straub DACalcium supplementation in clinical practice: a review of forms, doses, and indicationsNutr Clin Pract.(2007 Jun)
    123. ^Reid IR, Bristow SM, Bolland MJCalcium supplements: benefits and risksJ Intern Med.(2015 Oct)
    124. ^Edward RA, Szabo NJ, Tebbett IRLead Content of Calcium SupplementsJAMA.(2000 Sep)
    125. ^Kern J, Kern S, Blennow K, Zetterberg H, Waern M, Guo X, Börjesson-Hanson A, Skoog I, Östling SCalcium supplementation and risk of dementia in women with cerebrovascular diseaseNeurology.(2016 Oct 18)
    126. ^Maton PN, Burton MEAntacids revisited: a review of their clinical pharmacology and recommended therapeutic useDrugs.(1999 Jun)
    127. ^Chan JM, Giovannucci E, Andersson SO, Yuen J, Adami HO, Wolk ADairy products, calcium, phosphorous, vitamin D, and risk of prostate cancer (Sweden)Cancer Causes Control.(1998 Dec)
    128. ^Tseng M, Breslow RA, Graubard BI, Ziegler RGDairy, calcium, and vitamin D intakes and prostate cancer risk in the National Health and Nutrition Examination Epidemiologic Follow-up Study cohortAm J Clin Nutr.(2005 May)
    129. ^Giovannucci E, Liu Y, Stampfer MJ, Willett WCA prospective study of calcium intake and incident and fatal prostate cancerCancer Epidemiol Biomarkers Prev.(2006 Feb)
    130. ^Tavani A, Bertuccio P, Bosetti C, Talamini R, Negri E, Franceschi S, Montella M, La Vecchia CDietary intake of calcium, vitamin D, phosphorus and the risk of prostate cancerEur Urol.(2005 Jul)
    131. ^Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YHEffect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trialsInt J Cardiol.(2013 Oct 30)
    132. ^Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IREffect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysisBMJ.(2010 Jul 29)
    133. ^Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IRCalcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysisBMJ.(2011 Apr 19)
    134. ^Lewis JR, Zhu K, Prince RLAdverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementationJ Bone Miner Res.(2012 Mar)
    135. ^Lee WT, Leung SS, Leung DM, Cheng JCA follow-up study on the effects of calcium-supplement withdrawal and puberty on bone acquisition of childrenAm J Clin Nutr.(1996 Jul)
    136. ^Lambert HL, Eastell R, Karnik K, Russell JM, Barker MECalcium supplementation and bone mineral accretion in adolescent girls: an 18-mo randomized controlled trial with 2-y follow-upAm J Clin Nutr.(2008 Feb)
    137. ^Pronisceva V, Sebastian J, Joseph S, Sharp EA case report on over-replacement of oral calcium supplements causing acute pancreatitisAnn R Coll Surg Engl.(2014 Jan)
    138. ^Kato Y, Sato K, Sata A, Omori K, Nakajima K, Tokinaga K, Obara T, Takano KHypercalcemia induced by excessive intake of calcium supplement, presenting similar findings of primary hyperparathyroidismEndocr J.(2004 Dec)
    139. ^Picolos MK, Orlander PRCalcium carbonate toxicity: the updated milk-alkali syndrome; report of 3 cases and review of the literatureEndocr Pract.(2005 Jul-Aug)
    140. ^Cameron HUCalcium supplements and arthritisCMAJ.(1988 Feb 1)
    141. ^Caplan RH, Miller CD, Silva PDSevere hypercalcemia in a lactating woman in association with moderate calcium carbonate supplementation: a case reportJ Reprod Med.(2004 Mar)
    142. ^Koletzko B, Tangermann R, von Kries R, Stannigel H, Willberg B, Radde I, Schmidt EIntestinal milk-bolus obstruction in formula-fed premature infants given high doses of calciumJ Pediatr Gastroenterol Nutr.(1988 Jul-Aug)
    143. ^Lameris AL, Geesing CL, Hoenderop JG, Schreuder MFImportance of dietary calcium and vitamin D in the treatment of hypercalcaemia in Williams-Beuren syndromeJ Pediatr Endocrinol Metab.(2014 Jul)
    144. ^Vanpee D, Delgrange E, Gillet JB, Donckier JIngestion of antacid tablets (Rennie) and acute confusionJ Emerg Med.(2000 Aug)
    145. ^Renie WA, Pyeritz RE, Combs J, Fine SLPseudoxanthoma elasticum: high calcium intake in early life correlates with severityAm J Med Genet.(1984 Oct)
    146. ^Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, A Catharine Ross, Christine L Taylor, Ann L Yaktine, Heather B Del ValleDietary Reference Intakes for Calcium and Vitamin D
    147. ^Recker RRCalcium absorption and achlorhydria.N Engl J Med.(1985 Jul 11)
    148. ^Sakhaee K, Bhuket T, Adams-Huet B, Rao DSMeta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate.Am J Ther.(1999 Nov)
    149. ^Wood RJ, Serfaty-Lacrosniere CGastric acidity, atrophic gastritis, and calcium absorption.Nutr Rev.(1992 Feb)
    150. ^Afshan S, Farah Musa AR, Echols V, Lerant AA, Fülöp TPersisting Hypocalcemia After Surgical Parathyroidectomy: The Differential Effectiveness of Calcium Citrate Versus Calcium Carbonate With Acid Suppression.Am J Med Sci.(2017 Jan)
    151. ^Jamal SA, Vandermeer B, Raggi P, Mendelssohn DC, Chatterley T, Dorgan M, Lok CE, Fitchett D, Tsuyuki RTEffect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis.Lancet.(2013 Oct 12)
    152. ^Picolos MK, Lavis VR, Orlander PRMilk-alkali syndrome is a major cause of hypercalcaemia among non-end-stage renal disease (non-ESRD) inpatients.Clin Endocrinol (Oxf).(2005 Nov)
    153. ^Rout, P., Hashmi, M.F., & Patel, C.“Milk-Alkali Syndrome”, in StatPearls (Internet). USA: StatPearls Publishing(2024)
    154. ^Sadiq, N.M., Anastasopoulou, C., Patel, G., & Badireddy, M.“Hypercalcemia”, in StatPearls (Internet). USA: StatPearls Publishing(2024)
    155. ^Pokhrel, B., Leslie, S.W., & Levine, S.N.“Primary Hyperparathyroidism”, in StatPearls (Internet). USA: StatPearls Publishing(2024)
    156. ^Marcocci C, Bollerslev J, Khan AA, Shoback DMMedical management of primary hyperparathyroidism: proceedings of the fourth International Workshop on the Management of Asymptomatic Primary Hyperparathyroidism.J Clin Endocrinol Metab.(2014 Oct)
    157. ^Jorde R, Szumlas K, Haug E, Sundsfjord JThe effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake.Eur J Nutr.(2002 Dec)
    158. ^Vakiti, A., Anastasopoulou, C., & Mewawalla, P.“Malignancy-Related Hypercalcemia”, in StatPearls (Internet). USA: StatPearls Publishing(2023)
    159. ^Mirrakhimov AEHypercalcemia of Malignancy: An Update on Pathogenesis and Management.N Am J Med Sci.(2015 Nov)
    160. ^Messa P, Castellano G, Vettoretti S, Alfieri CM, Giannese D, Panichi V, Cupisti AVitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship.Nutrients.(2023 Mar 31)
    161. ^G C Curhan, W C Willett, F E Speizer, D Spiegelman, M J StampferComparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in womenAnn Intern Med.(1997 Apr 1)
    162. ^Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings SR, Granek I, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Johnson KC, Judd H, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, McGowan J, Ockene JK, O'Sullivan MJ, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D, Women's Health Initiative InvestigatorsCalcium plus vitamin D supplementation and the risk of fracturesN Engl J Med.(2006 Feb 16)
    163. ^Kahwati LC, Weber RP, Pan H, Gourlay M, LeBlanc E, Coker-Schwimmer M, Viswanathan MVitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA.(2018-04-17)
    164. ^Gary C Curhan, Walter C Willett, Eric L Knight, Meir J StampferDietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study IIArch Intern Med.(2004 Apr 26)
    165. ^Candelas G, Martinez-Lopez JA, Rosario MP, Carmona L, Loza ECalcium supplementation and kidney stone risk in osteoporosis: a systematic literature review.Clin Exp Rheumatol.(2012 Nov-Dec)
    166. ^Heaney RPCalcium supplementation and incident kidney stone risk: a systematic review.J Am Coll Nutr.(2008 Oct)
    167. ^Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CDCLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - EXECUTIVE SUMMARY.Endocr Pract.(2019 Dec)
    168. ^Tondapu P, Provost D, Adams-Huet B, Sims T, Chang C, Sakhaee KComparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass.Obes Surg.(2009 Sep)
    169. ^Ring Madsen L, Espersen R, Rejnmark L, Richelsen BEffect of calcium citrate vs calcium carbonate on elevated parathyroid hormone after Roux-en-Y gastric bypass. A double-blinded, randomized trial.Clin Endocrinol (Oxf).(2018 Dec)
    170. ^Hany M, Wuyts S, Abouelnasr AA, Zidan A, Demerdash HM, Hussein HASM, Arida RE, Elsharkawi SM, Kramers C, Torensma BComparison of calcium citrate and calcium carbonate absorption in patients with a Roux-en-Y gastric bypass, sleeve gastrectomy, and one-anastomosis gastric bypass: a double-blind, randomized cross-over trial.Surg Obes Relat Dis.(2024 Nov 6)
    171. ^Baretta GA, Cambi MP, Rodrigues AL, Mendes SASECONDARY HYPERPARATHYROIDISM AFTER BARIATRIC SURGERY: TREATMENT IS WITH CALCIUM CARBONATE OR CALCIUM CITRATE?Arq Bras Cir Dig.(2015)
    172. ^Rahmati S, Azami M, Delpisheh A, Hafezi Ahmadi MR, Sayehmiri KTotal Calcium (Dietary and Supplementary) Intake and Prostate Cancer: a Systematic Review and Meta-Analysis.Asian Pac J Cancer Prev.(2018 Jun 25)
    173. ^Dagfinn Aune, Deborah A Navarro Rosenblatt, Doris S M Chan, Ana Rita Vieira, Rui Vieira, Darren C Greenwood, Lars J Vatten, Teresa NoratDairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studiesAm J Clin Nutr.(2015 Jan)
    174. ^Chung M, Balk EM, Brendel M, Ip S, Lau J, Lee J, Lichtenstein A, Patel K, Raman G, Tatsioni A, Terasawa T, Trikalinos TAVitamin D and calcium: a systematic review of health outcomes.Evid Rep Technol Assess (Full Rep).(2009 Aug)
    175. ^Avenell A, MacLennan GS, Jenkinson DJ, McPherson GC, McDonald AM, Pant PR, Grant AM, Campbell MK, Anderson FH, Cooper C, Francis RM, Gillespie WJ, Robinson CM, Torgerson DJ, Wallace WA, RECORD Trial GroupLong-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and/or calcium (RECORD trial).J Clin Endocrinol Metab.(2012 Feb)
    176. ^Baron JA, Beach M, Wallace K, Grau MV, Sandler RS, Mandel JS, Heber D, Greenberg ERRisk of prostate cancer in a randomized clinical trial of calcium supplementation.Cancer Epidemiol Biomarkers Prev.(2005 Mar)
    177. ^Bruyère O, Deroisy R, Dardenne N, Cavalier E, Coffiner M, Da Silva S, De Niet S, Reginster JYA phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods.Osteoporos Int.(2015 Dec)
    178. ^Rondanelli M, Minisola S, Barale M, Barbaro D, Mansueto F, Battaglia S, Bonaccorsi G, Caliri S, Cavioni A, Colangelo L, Corbetta S, Coretti F, Dito G, Gavioli V, Ghigo E, Giannattasio R, Lapi P, Maiorana B, Marra C, Mazzantini M, Morini E, Nannipieri F, Nuzzo V, Parri F, Perna S, Santori R, Procopio MEvaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study.Aging Clin Exp Res.(2024 Feb 12)
    179. ^Wang Y, Xie G, Huang Y, Zhang H, Yang B, Mao ZCalcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis.PLoS One.(2015)
    180. ^Al-Mana, N. M. et alThe acute effects of calcium supplementation on appetite and satiety in overweight womenPNS.(2013-04-12)
    181. ^Gonzalez JT, Green BP, Brown MA, Rumbold PL, Turner LA, Stevenson EJCalcium ingestion suppresses appetite and produces acute overcompensation of energy intake independent of protein in healthy adults.J Nutr.(2015 Mar)
    182. ^Lorenzen JK, Nielsen S, Holst JJ, Tetens I, Rehfeld JF, Astrup AEffect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake.Am J Clin Nutr.(2007 Mar)
    183. ^Patel V, Mehra D, Ramirez B, Lindo A, Suarez MMilk-Alkali Syndrome as a Cause of Hypercalcemia in a Gentleman With Acute Kidney Injury and Excessive Antacid Intake.Cureus.(2021 Feb 1)
    184. ^Stoney B, Bagchi GAntacid abuse: a rare cause of severe hypercalcaemia.BMJ Case Rep.(2017 May 3)
    185. ^Medarov BIMilk-alkali syndrome.Mayo Clin Proc.(2009 Mar)
    186. ^Wang M, Cho C, Gray C, Chai TY, Daud R, Luttrell MMilk-alkali syndrome: a 'quick ease' or a 'long-lasting problem'.Endocrinol Diabetes Metab Case Rep.(2020 May 13)
    187. ^Ulett K, Wells B, Centor RHypercalcemia and acute renal failure in milk-alkali syndrome: a case report.J Hosp Med.(2010 Feb)
    188. ^Jain H, Murali S, Singh G, Amzuta ICalcium Carbonate (Tums)-Associated Hypercalcemic Crisis.Cureus.(2022 Dec)
    189. ^Bailey CS, Weiner JJ, Gibby OM, Penney MDExcessive calcium ingestion leading to milk-alkali syndrome.Ann Clin Biochem.(2008 Sep)
    190. ^Rout P, Hashmi MF, Patel CMilk-Alkali Syndrome.StatPearls.(2025 Jan)
    191. ^Sadiq, N.M., Anastasopoulou, C., Patel, G., & Badireddy, M.“Hypercalcemia”, in StatPearls (Internet). USA: StatPearls Publishing(2024)
    192. ^Chao Yang, Xiangling Shi, Hui Xia, Xian Yang, Hechun Liu, Da Pan, Guiju SunThe Evidence and Controversy Between Dietary Calcium Intake and Calcium Supplementation and the Risk of Cardiovascular Disease: A Systematic Review and Meta-Analysis of Cohort Studies and Randomized Controlled TrialsJ Am Coll Nutr.(May-Jun 2020)
    193. ^Seung-Kwon Myung, Hong-Bae Kim, Yong-Jae Lee, Yoon-Jung Choi, Seung-Won OhCalcium Supplements and Risk of Cardiovascular Disease: A Meta-Analysis of Clinical TrialsNutrients.(2021 Jan 26)
    194. ^John J B Anderson, Bridget Kruszka, Joseph A C Delaney, Ka He, Gregory L Burke, Alvaro Alonso, Diane E Bild, Matthew Budoff, Erin D MichosCalcium Intake From Diet and Supplements and the Risk of Coronary Artery Calcification and its Progression Among Older Adults: 10-Year Follow-up of the Multi-Ethnic Study of Atherosclerosis (MESA)J Am Heart Assoc.(2016 Oct 11)
    195. ^Marcus JF, Shalev SM, Harris CA, Goodin DS, Josephson SASevere hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution.Arch Neurol.(2012 Jan)
    196. ^Machado MC, Bruce-Mensah A, Whitmire M, Rizvi AAHypercalcemia Associated with Calcium Supplement Use: Prevalence and Characteristics in Hospitalized Patients.J Clin Med.(2015 Mar 9)
    197. ^Drinka PJ, Moore J, Boushon MCSevere hypercalcemia after transition from calcium carbonate to calcium citrate in an elderly woman treated with ergocalciferol 50,000 IU per day.Am J Geriatr Pharmacother.(2006 Mar)
    198. ^Singh A, Ashraf AHypercalcemic crisis induced by calcium carbonate.Clin Kidney J.(2012 Aug)
    199. ^Rehan MA, Rashid A, Krell K, Gabutti C, Singh RCalcium Alkali Thiazide Syndrome: What We Need to Know.Cureus.(2020 Oct 8)
    200. ^Desai HV, Gandhi K, Sharma M, Jennine M, Singh P, Brogan MThiazide-induced severe hypercalcemia: a case report and review of literature.Am J Ther.(2010 Nov-Dec)
    201. ^Parvez B, Emuwa C, Faulkner ML, Murray JJMilk alkali and hydrochlorothiazide: a case report.Case Rep Med.(2011)
    202. ^Hakim R, Tolis G, Goltzman D, Meltzer S, Friedman RSevere hypercalcemia associated with hydrochlorothiazide and calcium carbonate therapy.Can Med Assoc J.(1979 Sep 8)
    203. ^Liu H, Lu M, Hu J, Fu G, Feng Q, Sun S, Chen CMedications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.Ther Clin Risk Manag.(2023)
    204. ^Benvenga S, Di Bari F, Vita RUndertreated hypothyroidism due to calcium or iron supplementation corrected by oral liquid levothyroxine.Endocrine.(2017 Apr)
    205. ^Csako G, McGriff NJ, Rotman-Pikielny P, Sarlis NJ, Pucino FExaggerated levothyroxine malabsorption due to calcium carbonate supplementation in gastrointestinal disorders.Ann Pharmacother.(2001 Dec)
    206. ^Song I, Borland J, Arya N, Wynne B, Piscitelli SPharmacokinetics of dolutegravir when administered with mineral supplements in healthy adult subjects.J Clin Pharmacol.(2015 May)
    207. ^Rajesh Krishna, Lilly East, Patrick Larson, Chandni Valiathan, Kristin Butterfield, Yang Teng, Martha Hernandez-IllasEffect of metal-cation antacids on the pharmacokinetics of 1200 mg raltegravirJ Pharm Pharmacol.(2016 Nov)
    208. ^Federspiel J, Bukhari MJ, Hamill MMInteractions between highly active antiretroviral therapy and over-the-counter agents: a cautionary note.BMJ Case Rep.(2021 Jan 6)
    209. ^Rock AE, DeMarais PL, Vergara-Rodriguez PT, Max BEHIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and Bictegravir.Infect Dis Ther.(2020 Sep)
    210. ^Kang-Birken SL, El-Sayed D, Prichard JHIV Viral Rebound Due to a Possible Drug-Drug Interaction between Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide and Calcium-Containing Products: Report of 2 Cases.J Int Assoc Provid AIDS Care.(2019 Jan-Dec)
    211. ^Roberts, J. et alVirologic Failure with a Raltegravir-Containing Antiretroviral Regimen and Concomitant Calcium AdministrationPharmacotherapy.(January 6, 2012)
    212. ^P J NeuvonenInteractions with the absorption of tetracyclinesDrugs.(1976)
    213. ^Kakemi K, Sezaki H, Ogata H, Nadai TAbsorption and excretion of drugs. XXXVI. Effect of Ca2+ on the absorption of tetracycline from the small intestine. (1).Chem Pharm Bull (Tokyo).(1968 Nov)
    214. ^Wiesner A, Zagrodzki P, Gawalska A, Paśko PClinically important interactions of macrolides and tetracyclines with dietary interventions-a systematic review with meta-analyses.J Antimicrob Chemother.(2024 Nov 4)
    215. ^Bolhuis MS, Panday PN, Pranger AD, Kosterink JG, Alffenaar JWPharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams.Pharmaceutics.(2011 Nov 18)
    216. ^Wiesner A, Zagrodzki P, Gawalska A, Paśko PTogether or Apart? Revealing the Impact of Dietary Interventions on Bioavailability of Quinolones: A Systematic Review with Meta-analyses.Clin Pharmacokinet.(2024 Jun)
    217. ^Itoh A, Akagi Y, Shimomura H, Aoyama TInteraction between Bisphosphonates and Mineral Water: Study of Oral Risedronate Absorption in Rats.Biol Pharm Bull.(2016)
    218. ^Agnieszka Wiesner, Mariusz Szuta, Agnieszka Galanty, Paweł PaśkoOptimal Dosing Regimen of Osteoporosis Drugs in Relation to Food Intake as the Key for the Enhancement of the Treatment Effectiveness-A Concise Literature ReviewFoods.(2021 Mar 29)
    219. ^de Oliveira, P. et alAcute Effects Of Oral Calcium Carbonate With And Without The Addition Of Omeprazole And Fiber Enriched Milk On Serum Calcium Concentrations In Postmenopausal WomenInt Arch Med.(May 2017)
    220. ^Cervelli MJ, Shaman A, Meade A, Carroll R, McDonald SPEffect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.Nephrology (Carlton).(2012 Jul)
    221. ^Tatsuzawa M, Ogawa R, Ohkubo A, Shimojima K, Maeda K, Echizen H, Miyazaki AInfluence of proton pump inhibitors and histamine H(2) receptor antagonists on serum phosphorus level control by calcium carbonate in patients undergoing hemodialysis: a retrospective medical chart review.J Pharm Health Care Sci.(2016)
    222. ^O'Connell MB, Madden DM, Murray AM, Heaney RP, Kerzner LJEffects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial.Am J Med.(2005 Jul)
    223. ^Takahashi N, Shoji T, Matsubara K, Hitomi H, Hashimoto M, Kiyomoto H, Uchida K, Miki S, Hirohata M, Ishizu T, Akiyama K, Mizushige K, Matsuo H, Yuasa SEffect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients.J Am Soc Nephrol.(1999 May)
    224. ^Tan CC, Harden PN, Rodger RS, Rowe PA, Spooner RJ, Junor BJ, Briggs JDRanitidine reduces phosphate binding in dialysis patients receiving calcium carbonate.Nephrol Dial Transplant.(1996 May)
    225. ^Milman S, Epstein EJProton pump inhibitor-induced hypocalcemic seizure in a patient with hypoparathyroidism.Endocr Pract.(2011 Jan-Feb)
    226. ^Kahela P, Anttila M, Tikkanen R, Sundquist HEffect of food, food constituents and fluid volume on the bioavailability of sotalol.Acta Pharmacol Toxicol (Copenh).(1979 Jan)
    227. ^P Kahela, M Anttila, H SundqvistAntacids and sotalol absorptionActa Pharmacol Toxicol (Copenh).(1981 Sep)
    228. ^Vandermeulen L, Van Melkebeke L, Sienaert PLithium-associated hypercalcemia and hyperparathyroidism: A systematic review and meta-analysis.World J Biol Psychiatry.(2024 Oct)
    229. ^Argiratos V, Samman SThe effect of calcium carbonate and calcium citrate on the absorption of zinc in healthy female subjects.Eur J Clin Nutr.(1994 Mar)
    230. ^Cook JD, Dassenko SA, Whittaker PCalcium supplementation: effect on iron absorptionAm J Clin Nutr.(1991 Jan)
    231. ^Gaitán D, Flores S, Saavedra P, Miranda C, Olivares M, Arredondo M, López de Romaña D, Lönnerdal B, Pizarro FCalcium does not inhibit the absorption of 5 milligrams of nonheme or heme iron at doses less than 800 milligrams in nonpregnant womenJ Nutr.(2011 Sep)
    232. ^Miranda M, Olivares M, Brito A, Pizarro FReducing iron deficiency anemia in Bolivian school children: calcium and iron combined versus iron supplementation alone.Nutrition.(2014 Jul-Aug)
    233. ^Bar-Or D, Gasiel YCalcium and calciferol antagonise effect of verapamil in atrial fibrillation.Br Med J (Clin Res Ed).(1981 May 16)
    234. ^Salerno DM, Anderson B, Sharkey PJ, Iber CIntravenous verapamil for treatment of multifocal atrial tachycardia with and without calcium pretreatment.Ann Intern Med.(1987 Nov)
    235. ^Wohns DH, Patterson JH, Clarke S, Dunlap S, Blauwet MB, Koch G, Adams KF JrInfluence of calcium administration on the short-term hemodynamic and anti-ischemic effects of nifedipine.J Am Coll Cardiol.(1991 Oct)
    236. ^Haft JI, Habbab MATreatment of atrial arrhythmias. Effectiveness of verapamil when preceded by calcium infusion.Arch Intern Med.(1986 Jun)
    237. ^Moser LR, Smythe MA, Tisdale JEThe use of calcium salts in the prevention and management of verapamil-induced hypotension.Ann Pharmacother.(2000 May)
    238. ^Sato K, Dohi Y, Miyagawa K, Kojima MAcute antihypertensive effects of calcium channel blockers are not affected by calcium supplementation in patients with essential hypertension.Jpn Heart J.(1998 May)
    239. ^Nola GT, Pope S, Harrison DCAssessment of the synergistic relationship between serum calcium and digitalis.Am Heart J.(1970 Apr)
    240. ^Vella A, Gerber TC, Hayes DL, Reeder GSDigoxin, hypercalcaemia, and cardiac conduction.Postgrad Med J.(1999 Sep)
    241. ^Smith RB, Petruscak JSuccinylcholine, digitalis, and hypercalcemia: a case report.Anesth Analg.(1972 Mar-Apr)
    242. ^Carlon GC, Howland WS, Goldiner PL, Kahn RC, Bertoni G, Turnbull ADAdverse effects of calcium administration. Report of two cases.Arch Surg.(1978 Jul)
    243. ^Michael Levine, Heikki Nikkanen, Daniel J PallinThe effects of intravenous calcium in patients with digoxin toxicityJ Emerg Med.(2011 Jan)
    244. ^“Toxicological Profile for Strontium”, in Health Effects (Internet). USA: Agency for Toxic Substances and Disease Registry, cited February 2025(2004)
    245. ^Hardwick LL, Jones MR, Brautbar N, Lee DBMagnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate.J Nutr.(1991 Jan)
    246. ^Norman DA, Fordtran JS, Brinkley LJ, Zerwekh JE, Nicar MJ, Strowig SM, Pak CYJejunal and ileal adaptation to alterations in dietary calcium: changes in calcium and magnesium absorption and pathogenetic role of parathyroid hormone and 1,25-dihydroxyvitamin D.J Clin Invest.(1981 Jun)
    247. ^Clarkson EM, Warren RL, McDonald SJ, de Wardener HEThe effect of a high intake of calcium on magnesium metabolism in normal subjects and patients with chronic renal failure.Clin Sci.(1967 Feb)
    248. ^Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference IntakesDietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride
    249. ^Borel P, Desmarchelier C, Dumont U, Halimi C, Lairon D, Page D, Sébédio JL, Buisson C, Buffière C, Rémond DDietary calcium impairs tomato lycopene bioavailability in healthy humans.Br J Nutr.(2016 Dec)
    250. ^G Tsvetov, O Amitai, T Shochat, I Shimon, A Akirov, T Diker-CohenDenosumab-induced hypocalcemia in patients with osteoporosis: can you know who will get low?Osteoporos Int.(2020 Apr)
    251. ^Hirai T, Mori Y, Ogura T, Kondo Y, Sakazaki Y, Ishitsuka Y, Sudo A, Iwamoto TInfluence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis.J Pharm Health Care Sci.(2024 Sep 27)
    252. ^Thongprayoon C, Acharya P, Acharya C, Chenbhanich J, Bathini T, Boonpheng B, Sharma K, Wijarnpreecha K, Ungprasert P, Gonzalez Suarez ML, Cheungpasitporn WHypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies.Osteoporos Int.(2018 Aug)
    253. ^Miyaoka D, Imanishi Y, Ohara M, Hayashi N, Nagata Y, Yamada S, Mori K, Emoto M, Inaba MImpaired residual renal function predicts denosumab-induced serum calcium decrement as well as increment of bone mineral density in non-severe renal insufficiency.Osteoporos Int.(2019 Jan)
    254. ^Body JJ, Bone HG, de Boer RH, Stopeck A, Van Poznak C, Damião R, Fizazi K, Henry DH, Ibrahim T, Lipton A, Saad F, Shore N, Takano T, Shaywitz AJ, Wang H, Bracco OL, Braun A, Kostenuik PJHypocalcaemia in patients with metastatic bone disease treated with denosumab.Eur J Cancer.(2015 Sep)
    255. ^Vardi P, Benderly A, Etzioni A, Levy J, Hochberg ZHypocalcaemia induced by glucocorticoids in a child with hypoparathyroidism treated with 1-alpha-hydroxyvitamin D3.Eur J Pediatr.(1985 Sep)
    256. ^Brian L.Abstract #1177027: Severe Hypocalcemia Secondary to Glucocorticoid Use in a Patient with Hypoparathyroidism: A Case ReportEndocrine Practice.(2022-05-01)
    257. ^Kinoshita Y, Masuoka K, Miyakoshi S, Taniguchi S, Takeuchi YVitamin D insufficiency underlies unexpected hypocalcemia following high dose glucocorticoid therapy.Bone.(2008 Jan)
    258. ^Oikonomou D, Laina A, Xydaki A, Christopoulos CSteroid-induced hypocalcaemia with tetany in a patient with hypoparathyroidism.BMJ Case Rep.(2014 Nov 18)
    259. ^Conte PF, Latreille J, Mauriac L, Calabresi F, Santos R, Campos D, Bonneterre J, Francini G, Ford JMDelay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational randomized controlled trial. The Aredia Multinational Cooperative Group.J Clin Oncol.(1996 Sep)
    260. ^Kohno N, Aogi K, Minami H, Nakamura S, Asaga T, Iino Y, Watanabe T, Goessl C, Ohashi Y, Takashima SZoledronic acid significantly reduces skeletal complications compared with placebo in Japanese women with bone metastases from breast cancer: a randomized, placebo-controlled trial.J Clin Oncol.(2005 May 20)
    261. ^Champallou C, Basuyau JP, Veyret C, Chinet P, Debled M, Chevrier A, Grongnet MH, Brunelle PHypocalcemia following pamidronate administration for bone metastases of solid tumor: three clinical case reports.J Pain Symptom Manage.(2003 Feb)
    262. ^George Liamis, Haralampos J Milionis, Moses ElisafA review of drug-induced hypocalcemiaJ Bone Miner Metab.(2009)
    263. ^Clifford J Rosen, Sue BrownSevere hypocalcemia after intravenous bisphosphonate therapy in occult vitamin D deficiencyN Engl J Med.(2003 Apr 10)
    264. ^Do WS, Park JK, Park MI, Kim HS, Kim SH, Lee DHBisphosphonate-induced Severe Hypocalcemia - A Case Report -.J Bone Metab.(2012 Nov)
    265. ^Maalouf NM, Heller HJ, Odvina CV, Kim PJ, Sakhaee KBisphosphonate-induced hypocalcemia: report of 3 cases and review of literature.Endocr Pract.(2006 Jan-Feb)
    266. ^Lyles KW, Colón-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, Hyldstrup L, Recknor C, Nordsletten L, Moore KA, Lavecchia C, Zhang J, Mesenbrink P, Hodgson PK, Abrams K, Orloff JJ, Horowitz Z, Eriksen EF, Boonen S, HORIZON Recurrent Fracture TrialZoledronic acid and clinical fractures and mortality after hip fracture.N Engl J Med.(2007 Nov 1)
    267. ^Rosen LS, Gordon D, Kaminski M, Howell A, Belch A, Mackey J, Apffelstaedt J, Hussein MA, Coleman RE, Reitsma DJ, Chen BL, Seaman JJLong-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma: a randomized, double-blind, multicenter, comparative trial.Cancer.(2003 Oct 15)
    268. ^Rosen LS, Gordon D, Tchekmedyian S, Yanagihara R, Hirsh V, Krzakowski M, Pawlicki M, de Souza P, Zheng M, Urbanowitz G, Reitsma D, Seaman JJZoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.J Clin Oncol.(2003 Aug 15)
    269. ^Kakajiwala A, Barton KT, Rampolla E, Breen C, Pradhan MAcute Hypocalcemia and Metabolic Alkalosis in Children on Cation-Exchange Resin Therapy.Case Rep Nephrol.(2017)
    270. ^Le Palma K, Pavlick ER, Copelovitch LPretreatment of enteral nutrition with sodium polystyrene sulfonate: effective, but beware the high prevalence of electrolyte derangements in clinical practice.Clin Kidney J.(2018 Apr)
    271. ^Berends AMA, van der Horst-Schrivers ANA, Oosting SF, Kapiteijn EW, de Groot JWB, Links TPHypocalcemia induced by tyrosine kinase inhibitors: targeted treatment with 'untargeted' side effects.Acta Oncol.(2020 Jun)
    272. ^Trevisan M, Colombo C, Giancola N, Moneta C, Dionigi G, Fugazzola L, De Leo SLenvatinib-induced hypocalcaemia due to transient primary hypoparathyroidism.Endocrine.(2022 Oct)
    273. ^Yusuf B, McPhedran P, Brewster UCHypocalcemia in a dialysis patient treated with deferasirox for iron overload.Am J Kidney Dis.(2008 Sep)
    274. ^Syeda Z. S. J., et alCinacalcet. StatPearls (Internet). USA: StatPearls Publishing(2024)
    275. ^Floege J, Tsirtsonis K, Iles J, Drueke TB, Chertow GM, Parfrey PIncidence, predictors and therapeutic consequences of hypocalcemia in patients treated with cinacalcet in the EVOLVE trial.Kidney Int.(2018 Jun)
    276. ^Huycke MM, Naguib MT, Stroemmel MM, Blick K, Monti K, Martin-Munley S, Kaufman CA double-blind placebo-controlled crossover trial of intravenous magnesium sulfate for foscarnet-induced ionized hypocalcemia and hypomagnesemia in patients with AIDS and cytomegalovirus infection.Antimicrob Agents Chemother.(2000 Aug)
    277. ^Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AAFoscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.J Clin Endocrinol Metab.(1991 May)
    278. ^Foscarnet. Prescribing information. Clinigen Healthcare Ltd. cited Dec 2025(202)
    279. ^Noormohamed FH, Youle MS, Tang B, Martin-Munley S, Gazzard BG, Lant AFFoscarnet-induced changes in plasma concentrations of total and ionized calcium and magnesium in HIV-positive patients.Antivir Ther.(1996 Aug)
    280. ^Akbar A, Rees JH, Nyamugunduru G, English MW, Spencer DA, Weller PHAminoglycoside-associated hypomagnesaemia in children with cystic fibrosis.Acta Paediatr.(1999 Jul)
    281. ^Zaloga GP, Chernow B, Pock A, Wood B, Zaritsky A, Zucker AHypomagnesemia is a common complication of aminoglycoside therapy.Surg Gynecol Obstet.(1984 Jun)
    282. ^Liamis G, Hoorn EJ, Florentin M, Milionis HAn overview of diagnosis and management of drug-induced hypomagnesemia.Pharmacol Res Perspect.(2021 Aug)
    283. ^Kelnar CJ, Taor WS, Reynolds DJ, Smith DR, Slavin BM, Brook CGHypomagnesaemic hypocalcaemia with hypokalaemia caused by treatment with high dose gentamicin.Arch Dis Child.(1978 Oct)
    284. ^Singh J, Patel ML, Gupta KK, Pandey S, Dinkar AAcquired Bartter syndrome following gentamicin therapy.Indian J Nephrol.(2016 Nov-Dec)
    285. ^Landau D, Kher KKGentamicin-induced Bartter-like syndrome.Pediatr Nephrol.(1997 Dec)
    286. ^Uehara A, Kita Y, Sumi H, Shibagaki YProton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.Intern Med.(2019 Aug 1)
    287. ^Sivakumar JProton pump inhibitor-induced hypomagnesaemia and hypocalcaemia: case review.Int J Physiol Pathophysiol Pharmacol.(2016)
    288. ^Zaya NE, Woodson GProton pump inhibitor suppression of calcium absorption presenting as respiratory distress in a patient with bilateral laryngeal paralysis and hypocalcemia.Ear Nose Throat J.(2010 Feb)
    289. ^Camila Costa Souza, Larissa G Rigueto, Henrique Costa Santiago, Antonio Carlos Seguro, Adriana Castello Girardi, Weverton Machado LuchiMultiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literatureClin Nephrol Case Stud.(2024 Jan 4)
    290. ^Ewout J Hoorn, Joost van der Hoek, Rob A de Man, Ernst J Kuipers, Clemens Bolwerk, Robert ZietseA case series of proton pump inhibitor-induced hypomagnesemiaAm J Kidney Dis.(2010 Jul)
    291. ^Gröber UMagnesium and Drugs.Int J Mol Sci.(2019-Apr-28)
    292. ^Hess MW, Hoenderop JG, Bindels RJ, Drenth JPSystematic review: hypomagnesaemia induced by proton pump inhibition.Aliment Pharmacol Ther.(2012 Sep)
    293. ^Atkinson NS, Reynolds DJ, Travis SP'Lemonade Legs': Why do Some Patients Get Profound Hypomagnesaemia on Proton-Pump Inhibitors?Intest Res.(2015 Jul)
    294. ^Gröber U, Schmidt J, Kisters KImportant drug-micronutrient interactions: A selection for clinical practice.Crit Rev Food Sci Nutr.(2020)
    295. ^Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto TAcute-onset hypomagnesemia-induced hypocalcemia caused by the refractoriness of bones and renal tubules to parathyroid hormone.J Bone Miner Metab.(2011 Nov)
    296. ^M Elisaf, H Milionis, K C SiamopoulosHypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristicsMiner Electrolyte Metab.(1997)
    297. ^Uwe Gröber, Klaus KistersInfluence of drugs on vitamin D and calcium metabolismDermatoendocrinol.(2012 Apr 1)
    298. ^LoPinto-Khoury C, Brennan L, Mintzer SImpact of carbamazepine on vitamin D levels: A meta-analysis.Epilepsy Res.(2021 Dec)
    299. ^Kim Robien, Sarah J Oppeneer, Julia A Kelly, Jill M Hamilton-ReevesDrug-vitamin D interactions: a systematic review of the literatureNutr Clin Pract.(2013 Apr)
    300. ^Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan NA comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy.Q J Med.(1986 Jun)
    301. ^N Collins, J Maher, M Cole, M Baker, N CallaghanA prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalaciaQ J Med.(1991 Feb)
    302. ^Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan GEffect of antiepileptic drugs on bone density in ambulatory patients.Neurology.(2002 May 14)
    303. ^Burckhardt P, Ruedi B, Felber JPEstrogen-induced tetany in idiopathic hypoparathyroidism.Horm Res.(1975)
    304. ^C Nagant de DeuxchaisnesOestrogen-induced hypocalcaemia in hypoparathyroidismBr Med J.(1979 Jun 9)
    305. ^S A Vogelgesang, J M McMillinHypocalcemia associated with estrogen therapy for metastatic adenocarcinoma of the prostateJ Urol.(1988 Nov)
    306. ^Kim M, Kim C, Song IAnalysis of lead in 55 brands of dietary calcium supplements by graphite furnace atomic absorption spectrometry after microwave digestion.Food Addit Contam.(2003 Feb)
    307. ^Scelfo GM, Flegal ARLead in calcium supplements.Environ Health Perspect.(2000 Apr)
    308. ^Bourgoin BP, Evans DR, Cornett JR, Lingard SM, Quattrone AJLead content in 70 brands of dietary calcium supplements.Am J Public Health.(1993 Aug)
    309. ^Ross EA, Szabo NJ, Tebbett IRLead content of calcium supplements.JAMA.(2000 Sep 20)
    310. ^Mattos JC, Hahn M, Augusti PR, Conterato GM, Frizzo CP, Unfer TC, Dressler VL, Flores EM, Emanuelli TLead content of dietary calcium supplements available in Brazil.Food Addit Contam.(2006 Feb)
    311. ^Rehman S, Adnan M, Khalid N, Shaheen LCalcium supplements: an additional source of lead contamination.Biol Trace Elem Res.(2011 Oct)
    312. ^Imdad A, Bhutta ZAEffects of calcium supplementation during pregnancy on maternal, fetal and birth outcomes.Paediatr Perinat Epidemiol.(2012 Jul)
    313. ^Kolnick L, Harris BD, Choma DP, Choma NNHypercalcemia in pregnancy: a case of milk-alkali syndrome.J Gen Intern Med.(2011 Aug)
    314. ^Addington S, Larson N, Scofield RHMilk-alkali syndrome in pre-eclamptic pregnancy: report of a patient and evaluation of albumin-corrected calcium in pre-eclamptic pregnancies.J Okla State Med Assoc.(2006 Sep)
    315. ^Picolos MK, Sims CR, Mastrobattista JM, Carroll MA, Lavis VRMilk-alkali syndrome in pregnancy.Obstet Gynecol.(2004 Nov)
    316. ^Robertson WC JrCalcium carbonate consumption during pregnancy: an unusual cause of neonatal hypocalcemia.J Child Neurol.(2002 Nov)
    317. ^Borkenhagen JF, Connor EL, Stafstrom CENeonatal hypocalcemic seizures due to excessive maternal calcium ingestion.Pediatr Neurol.(2013 Jun)
    318. ^Jarjou LM, Prentice A, Sawo Y, Laskey MA, Bennett J, Goldberg GR, Cole TJRandomized, placebo-controlled, calcium supplementation study in pregnant Gambian women: effects on breast-milk calcium concentrations and infant birth weight, growth, and bone mineral accretion in the first year of life.Am J Clin Nutr.(2006 Mar)
    319. ^A Prentice, L M Jarjou, T J Cole, D M Stirling, B Dibba, S Fairweather-TaitCalcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretionAm J Clin Nutr.(1995 Jul)
    320. ^Anand G., et alHypomagnesemia-Induced Hypocalcemia Successfully Treated With Sodium-Glucose Cotransport Inhibitor (SGLT-2i), a Case ReportJ Endocr Soc.(2021-05-03)
    321. ^Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hamilton E, Hofland J, Jan de Beur S, Kalra S, Kaltsas G, Kapoor N, Kim M, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, Muzumdar R, Purnell J, Rey R, Sahay R, Shah AS, Sperling MA, Stratakis CA, Trence DL, Wilson DP, Schafer AL, Shoback DMHypocalcemia: Diagnosis and Treatment.Endotext.(2000)